CardiologyDrug cut Lp(a) cholesterol by 78% yet heart attacks did not fall
In the 8,322-patient Lp(a) HORIZON trial, monthly pelacarsen injections slashed lipoprotein(a) levels, but heart attacks, strokes and heart deaths stayed level with placebo for almost five years.
7 November 2026